Alkylation of Amines with Alcohols
FULL PAPER
solvent was removed under vacuum. After purification by column chro-
matography (SiO2; CH2Cl2/MeOH, 90:10), 7 (149.7 mg, 84% yield) was
obtained as a yellow powder. 1H NMR (CDCl3): d=7.44 (d, J=2 Hz,
1H; CHimidazol backbone), 7.02 (d, J=2 Hz, 1H; CHimidazol backbone), 5.11 (d, J=
Intermediate I was also prepared by an alternative
method from complex 9 and AgBF4, and could be fully char-
acterized by NMR spectroscopic and HRMS analyses. The
1H NMR spectrum of I obtained in this way was identical to
that obtained by reacting 1a with proton sponge. Further-
more, when intermediate I was used as the catalyst, the re-
action time decreased from 2 to 1 h (Table 1, entry 10). This
suggests that alkoxide complex I may be an intermediate in
the reaction cycle.
Bifunctional complex II contains basic (oxygen) and
acidic (iridium) sites. Thus, II is capable of accepting a
proton and a hydride, producing complex III (Scheme 5).
The exact mechanism of the dehydrogenation step is un-
known at this stage of the investigation. Both an outer-
sphere type (proceeding without coordination of the alcohol
to the metal center) and an inner-sphere type (involving
direct coordination of the alcohol to iridium and b-hydride
elimination) may be possible. The aldehyde produced
during the dehydrogenation step condenses with the amine,
forming an imine intermediate. Bifunctional complex III,
which contains both hydride and proton-donating sites, sub-
sequently rehydrogenates the imine, closing the catalytic
cycle. Similar to the dehydrogenation, the imine hydrogena-
tion step may also proceed through inner- or outer-sphere
mechanisms.
14.0 Hz, 1H; NCHHC
butyl), 3.81 (dt, J=12.2, 5.3 Hz, 1H; CHHn-butyl), 3.66 (d, J=14.0 Hz, 1H;
NCHHC(CH3)2OH), 3.06 (brs, 1H; OH), 2.13–1.97 (m, 1H; CHHn-butyl),
1.81–1.65 (m, 1H; CHHn-butyl), 1.57–1.40 (m, 2H; CH2n-butyl), 1.58 (s, 15H;
5A(CH3)5), 1.40 (s, 3H; C(CH3)2OH), 1.39 (s, 3H; C(CH3)2OH), 0.99 ppm
(t, J=7.4 Hz, 3H; CH3n-butyl); C NMR (CDCl3): d=156.0 (Ir C), 122.8
(CHimidazol backbone), 121.1 (CHimidazol backbone), 88.8 (C5A(CH3)5), 70.1 (NCH2C-
(CH3)2O), 59.1 (NCH2C(CH3)2O), 50.7 (CH2n-butyl), 34.0 (CH2n-butyl), 28.7
((CH3)2OH), 27.8 ((CH3)2OH), 20.2 (CH2n-butyl), 14.0 (CH3n-butyl), 9.0 ppm
5A
ACHTUGNRTEN(NGNU CH3)2OH), 4.77 (dt, J=12.2, 5.3 Hz, 1H; CHHn-
AHCTUNGTRENNUNG
C
G
E
ACHTUNGTRENNUNG
13
À
CTHUNGTRENNUNG
A
ACHTUNGTRENNUNG
(C CHUTGNTERN(NUNG CH3)5); HRMS (ESI+): m/z calcd for C21H35ClIrN2O: 559.2062
[MÀCl]+; found: 559.2085; elemental analysis calcd (%) for
C21H37Cl2IrN2O: C 42.27, H 6.25, Cl 11.88, N 4.70; found: C 42.07, H
5.87, Cl 11.16, N 4.33.
Preparation of complex 1a: A solution of AgBF4 (28.8 mg, 0.15 mmol) in
anhydrous and degassed MeCN (0.25 mL) was added to an oven-dried
sealed microwave tube containing complex 7 (44.6 mg, 0.075 mmol) in
acetonitrile (0.5 mL) under an argon atmosphere. The reaction mixture
was stirred for 15 min at RT, then the resulting crude solution was fil-
tered through Celite and the solvent was evaporated. After precipitation
from a CH2Cl2/pentane solution, complex 1a (41.6 mg, 75% yield) was
obtained as a yellow powder. 1H NMR ([D6]acetone): d=7.71 (d, J=
2.1 Hz, 1H; CHimidazol backbone), 7.65 (d, J=2.1 Hz, 1H; CHimidazol backbone),
7.02 (brs, 1H; OH), 4.40 (d, J=15.0 Hz, 1H; NCHHC
(ddd, J=13.3, 10.7, 6.5 Hz, 1H; CHHn-butyl), 4.18 (ddd, J=13.3, 10.7,
6.5 Hz, 1H; CHHn-butyl), 3.89 (d, J=15.0 Hz, 1H; NCHHC(CH3)2OH),
2.80 (s, 3H; CH3CN), 2.14–1.80 (m, 2H; CH2n-butyl), 1.85 (s, 15H; C5-
(CH3)5), 1.61 (s, 3H; C(CH3)2OH), 1.59–1.47 (m, 2H; CH2n-butyl), 1.03 (t,
ACHTUGNTREN(UNNG CH3)2OH), 4.37
AHCTUNGTRENNUNG
A
ACHTUNGTRENNUNG
It is important to mention that the relatively high catalytic
activity of complex 14 (Table 1, entry 11), containing a
methyl substituent on the oxygen atom, indicates that this
complex operates through a different mechanism in which
the proton-accepting capability is not crucial for catalysis.
J=7.5 Hz, 3H; CH3n-butyl), 0.98 ppm (s, 3H;
CACTHNGUTERNNUG
(CH3)2OH); 13C NMR
À
([D6]acetone): d=152.8 (Ir C), 126.8 (CHimidazol backbone), 126.4 (CH3CN),
122.3 (CHimidazol backbone), 93.6 (C
5A
G
(NCH2C
ACHTUNGTRENNUNG
22.7 ((CH3)2OH), 20.6 (CH2n-butyl), 14.1 (CH3n-butyl), 9.4 (C CHTUNGTRENNUNG
3.8 ppm (CH3CN); IR (NaCl, selected bands): n˜ =3625–3500 (br), 1000–
1100 cmÀ1 (two bands overlapping, s); HRMS (ESI+): m/z calcd for
C21H34IrN2O: 523.2295 [M]+; found: 523.2312.
Conclusion
General procedure for the alkylation of amines with alcohols catalyzed
by 1a: A solution of AgBF4 (28.8 mg, 0.15 mmol) in anhydrous and de-
gassed MeCN (0.25 mL) was added to an oven-dried sealed tube contain-
ing pre-catalyst 7 (45 mg, 0.075 mmol) in MeCN (0.5 mL) under an argon
atmosphere. The reaction mixture was stirred for 15 min at RT, then the
resulting solution was filtered by using a cannula under an argon atmos-
phere and used as the stock solution for catalysis. The solution containing
the catalyst (0.1–0.25 mL) was added to a solution of alcohol (1 mmol)
and amine (1 mmol) in anhydrous and degassed toluene (0.4 mL) under
an argon atmosphere. The reaction mixture was stirred at 1108C for the
time indicated in Tables 3 and 4. After completion, the mixture was
cooled, filtered, and concentrated. The products were purified by column
chromatography (SiO2; pentane/CH2Cl2 =90:10 to 80:20; or pentane/
EtOAc=100:0 to 70:30). For those reactions that were run at 508C, the
active catalyst was prepared in situ from 7 and AgBF4 (2 equiv) in
CH2Cl2 and used in the reaction (Ir=2 mol%) after filtration through
Celite to remove AgCl. The reaction was carried out in a mixture of
CH2Cl2/toluene (1:4) for the time indicated in Tables 3 and 4.
We have synthesized new N-heterocyclic carbene ligands
containing a hydroxyl moiety that allow, for the first time,
the preparation of iridium complexes with chelating [NHC
alcohol] ligands. The unique properties of the complexes ac-
count for their high catalytic activity in the N-alkylation of
amines with alcohols. The best catalyst displays a broad sub-
strate scope and is one of the most active catalysts known to
date; it can be used to catalyze the reaction at temperatures
as low as 508C. A reaction mechanism involving complex 1a
has been proposed. Key intermediates are a bifunctional
À
iridACHTUNGTRENNUNGium alkoxide complex (II), which was prepared and char-
acterized, and bifunctional iridium hydride complex III.
Encouraged by these results, we are currently investigat-
ing the mechanism further and developing a solid-supported
version of this catalyst. Our results will be communicated in
due course.
X-ray crystallography: Crystallographic data and refinement are provided
in Table 1 in the Supporting Information. CCDC-867806 (1a), CCDC-
867807 (7), CCDC-868525 (9), CCDC-881979 (13), and CCDC-868780
(14) contain the supplementary crystallographic data for this paper.
These data can be obtained free of charge from The Cambridge Crystal-
Experimental Section
Preparation of complex 7: A mixture of [IrCp*Cl2]2 (119 mg, 0.15 mmol)
and silver carbene 6 (101.4 mg, 0.3 mmol, 0.3m in CH2Cl2) was stirred at
358C for 4 h. The reaction mixture was filtered through Celite and the
Chem. Eur. J. 2012, 00, 0 – 0
ꢂ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
&
7
&
ÞÞ
These are not the final page numbers!